Extracellular vesicle, CRISPR-Cas13a, PD-L1 mRNA, Membrane fusion, in situ detection single vesicle analysis, Immunotherapy
Concurrent chemoradiotherapy, immune checkpoint inhibitor, esophageal cancer, cohort study